Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding.

PubWeight™: 1.88‹?› | Rank: Top 3%

🔗 View Article (PMC 237399)

Published in J Virol on January 01, 1993

Authors

Y Li1, L Luo, N Rasool, C Y Kang

Author Affiliations

1: Department of Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ontario, Canada.

Articles citing this

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol (2002) 6.11

Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88

Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol (1994) 3.39

Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J Virol (1997) 2.88

Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. J Virol (2010) 2.76

Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol (1999) 2.48

N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies. J Virol (2004) 2.10

Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02

Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate. J Virol (2003) 2.00

Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol (1995) 1.99

Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J Virol (2010) 1.89

A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J Virol (1997) 1.85

Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J Proteome Res (2008) 1.73

Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. J Virol (2002) 1.69

Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors. J Virol (2005) 1.68

The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc Natl Acad Sci U S A (1995) 1.65

Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. J Proteome Res (2009) 1.61

Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus. J Virol (2002) 1.54

Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J Biol Chem (2010) 1.48

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120. J Virol (1996) 1.46

Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques. J Virol (2006) 1.45

Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. J Virol (1998) 1.39

Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein. J Virol (1998) 1.39

Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3. J Virol (2004) 1.31

Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate. J Virol (2001) 1.31

Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected. J Virol (2011) 1.27

Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope. PLoS Comput Biol (2006) 1.25

Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J Virol (2000) 1.16

Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J Virol (2005) 1.13

A lectin isolated from bananas is a potent inhibitor of HIV replication. J Biol Chem (2010) 1.12

Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. Proc Natl Acad Sci U S A (1996) 1.10

The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion. Retrovirology (2008) 1.10

Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model. J Virol (2009) 1.05

Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site. J Virol (1997) 1.04

epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals. J Virol (2011) 1.04

Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes. J Immunol (2009) 1.02

Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140. J Virol (2015) 0.97

Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site. J Virol (2011) 0.97

Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies. J Biol Chem (2010) 0.96

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies. Nat Commun (2015) 0.92

Substitution of asparagine residues in Aspergillus awamori glucoamylase by site-directed mutagenesis to eliminate N-glycosylation and inactivation by deamidation. Biochem J (1994) 0.91

Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein. J Virol (2007) 0.91

Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. Virology (2008) 0.89

Functional contributions of carbohydrate on AIDS virus glycoprotein. Yale J Biol Med (2010) 0.87

Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches. Biomark Med (2009) 0.86

Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells. Antimicrob Agents Chemother (1994) 0.86

Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate. J Virol (2005) 0.85

Conservation, Compensation, and Evolution of N-Linked Glycans in the HIV-1 Group M Subtypes and Circulating Recombinant Forms. ISRN AIDS (2012) 0.83

The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop. PLoS One (2013) 0.82

Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection. AIDS Res Ther (2014) 0.82

A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system. J Virol (1996) 0.81

Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission. J Virol (2014) 0.80

Engineering and exploitation of a fluorescent HIV-1 gp120 for live cell CD4 binding assays. Virology (2014) 0.78

Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN. Virology (2013) 0.77

Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus. Retrovirology (2015) 0.77

Differential dependence on N-glycosylation of anthrax toxin receptors CMG2 and TEM8. PLoS One (2015) 0.75

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. Nat Commun (2017) 0.75

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group. Clin Diagn Lab Immunol (1996) 0.75

Articles cited by this

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57

Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Anal Biochem (1980) 14.14

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (1986) 10.62

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science (1986) 6.33

Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells. Proc Natl Acad Sci U S A (1984) 5.81

Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J Immunol (1986) 5.31

Regulation of protein export from the endoplasmic reticulum. Annu Rev Cell Biol (1988) 4.53

Identification of the residues in human CD4 critical for the binding of HIV. Cell (1989) 3.71

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A (1987) 3.47

Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell (1988) 3.40

A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell (1990) 2.63

Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J Biol Chem (1988) 2.48

Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding. J Biol Chem (1988) 2.30

Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene (1991) 2.13

Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding. J Virol (1989) 1.97

Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol Cell Biol (1989) 1.87

Model for intracellular folding of the human immunodeficiency virus type 1 gp120. J Virol (1989) 1.70

Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. Virology (1989) 1.41

Enzymatic approaches for studying the structure, synthesis, and processing of glycoproteins. Methods Cell Biol (1989) 1.40

Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D. J Virol (1989) 1.38

Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins. J Virol (1989) 1.35

Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. J Virol (1990) 1.35

Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis. J Exp Med (1989) 1.20

Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells. Virology (1990) 1.13

Reduction in CD4 binding affinity associated with removal of a single glycosylation site in the external glycoprotein of HIV-2. Virology (1991) 1.12

Expression of HIV-1 gp120 and human soluble CD4 by recombinant baculoviruses and their interaction in vitro. AIDS Res Hum Retroviruses (1990) 1.00

Inhibition of glycosylation of viral glycoproteins. Biochem Soc Trans (1979) 0.95

Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity. Virus Res (1990) 0.89

Effect of glycosylation on the conformational epitopes of the glycoprotein of vesicular stomatitis virus (New Jersey serotype). Virology (1991) 0.87

HIV-1 envelope protein gp120 expression by secretion in E. coli: assessment of CD4 binding and use in epitope mapping. J Virol Methods (1990) 0.87

Articles by these authors

Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron (1999) 17.62

Mosaic analysis with a repressible cell marker (MARCM) for Drosophila neural development. Trends Neurosci (2001) 6.99

Proteins of vesicular stomatitis virus. I. Polyacrylamide gel analysis of viral antigens. J Virol (1969) 5.01

Development of the Drosophila mushroom bodies: sequential generation of three distinct types of neurons from a neuroblast. Development (1999) 3.96

Drosophila Rho-associated kinase (Drok) links Frizzled-mediated planar cell polarity signaling to the actin cytoskeleton. Cell (2001) 3.65

Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity. J Virol (1973) 3.62

Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons. J Neurosci (2000) 3.21

Proteins of vesicular stomatitis virus. 3. Intracellular synthesis and extracellular appearance of virus-specific proteins. Virology (1971) 3.17

Target neuron prespecification in the olfactory map of Drosophila. Nature (2001) 3.07

Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat Cell Biol (2000) 3.05

Proteins of vesicular stomatitis virus. II. Immunological comparisons of viral antigens. J Virol (1970) 2.90

Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature (1996) 2.81

Random numbers certified by Bell's theorem. Nature (2010) 2.75

Disassembly of the Mu transposase tetramer by the ClpX chaperone. Genes Dev (1995) 2.72

Reticuloendotheliosis virus nucleic acid sequences in cellular DNA. J Virol (1974) 2.55

Oligonucleotide fingerprints of RNA species obtained from rhabdoviruses belonging to the vesicular stomatitis virus subgroup. J Virol (1977) 2.35

Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis. Neuron (2000) 2.31

A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature (2000) 2.27

Somatic mitochondrial DNA mutations in adult-onset leukaemia. Leukemia (2003) 2.26

The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol (1995) 2.10

Cell-autonomous requirement of the USP/EcR-B ecdysone receptor for mushroom body neuronal remodeling in Drosophila. Neuron (2000) 2.09

Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02

Identification of residues in the Mu transposase essential for catalysis. Proc Natl Acad Sci U S A (1994) 1.94

Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines. Curr Opin Chem Biol (2001) 1.93

How do dendrites take their shape? Nat Neurosci (2001) 1.91

Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature (1996) 1.84

Phantom sensations generated by thalamic microstimulation. Nature (1998) 1.83

Complete transposition requires four active monomers in the mu transposase tetramer. Genes Dev (1994) 1.83

Regulating axon branch stability: the role of p190 RhoGAP in repressing a retraction signaling pathway. Cell (2001) 1.79

CDC42 and Rac1 control different actin-dependent processes in the Drosophila wing disc epithelium. J Cell Biol (1995) 1.77

Homotypic and heterotypic interference by defective particles of vesicular stomatitis virus. Nature (1970) 1.71

The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit. J Biol Chem (1999) 1.62

Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children. Neurology (2005) 1.59

Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system. J Comp Neurol (1999) 1.57

Endogenous RNA-directed DNA polymerase activity in uninfected chicken embryos. Proc Natl Acad Sci U S A (1972) 1.49

Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J Immunol (1992) 1.47

Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3. J Virol (1984) 1.46

Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells. Virology (1990) 1.45

The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology (1991) 1.43

ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem (2000) 1.42

Torsional ultrasound modality for hard nucleus phacoemulsification cataract extraction. Br J Ophthalmol (2008) 1.40

Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene (2006) 1.40

split ends encodes large nuclear proteins that regulate neuronal cell fate and axon extension in the Drosophila embryo. Development (2000) 1.36

Antigenuria in St. Louis encephalitis. Am J Trop Med Hyg (1980) 1.34

Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology (1991) 1.33

Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet (1997) 1.32

Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences. Virology (1994) 1.27

The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res (1996) 1.26

Endogenous RNA-directed DNA polymerase activity in virions of RNA tumor viruses and in a fraction from normal chicken cells. Methods Enzymol (1974) 1.25

Studies on the generation of vesicular stomatitis virus (indiana serotype) defective interfering particles. Virology (1978) 1.24

Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J Control Release (2004) 1.23

Expression of small-conductance calcium-activated potassium channels (SK) in outer hair cells of the rat cochlea. Eur J Neurosci (1998) 1.22

Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19

Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol (1994) 1.19

Anterolateral thigh flap: A review of 168 cases. Microsurgery (1999) 1.19

Nucleotide sequence analysis of the S genomic segment of Prospect Hill virus: comparison with the prototype Hantavirus. Virology (1990) 1.17

Glycosylation is not required for the fusion activity of the G protein of vesicular stomatitis virus in insect cells. Virology (1989) 1.17

Nucleotide sequence analysis of the L gene of vesicular stomatitis virus (New Jersey serotype): identification of conserved domains in L proteins of nonsegmented negative-strand RNA viruses. Virology (1990) 1.16

Intracellular signaling pathways that regulate dendritic spine morphogenesis. Hippocampus (2000) 1.15

Conformational changes induced in the endoplasmic reticulum luminal domain of calnexin by Mg-ATP and Ca2+. J Biol Chem (1995) 1.14

A 3D Static Heart Model From a MSCT Data Set. Conf Proc IEEE Eng Med Biol Soc (2005) 1.12

Caspase 8 and human villous cytotrophoblast differentiation. Placenta (2010) 1.12

Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. Proc Natl Acad Sci U S A (1996) 1.10

Molecular characterization of the Prospect Hill virus M RNA segment: a comparison with the M RNA segments of other hantaviruses. J Gen Virol (1991) 1.09

Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects. Carcinogenesis (2001) 1.09

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. Cell Death Dis (2013) 1.09

Moment-based approaches in imaging part 2: invariance. IEEE Eng Med Biol Mag (2008) 1.09

ATM mutations in cancer families. Cancer Res (1996) 1.09

Traumatic carotid cavernous fistula concomitant with pseudoaneurysm in the sphenoid sinus. Interv Neuroradiol (2008) 1.08

Transformation of chick embryo fibroblasts by reticuloendotheliosis virus. Virology (1977) 1.08

Femtosecond population inversion and stimulated emission of dense Dirac fermions in graphene. Phys Rev Lett (2012) 1.08

Early DNA-RNA complex from the endogenous RNA-directed DNA polymerase activity of uninfected chicken embryos. Nat New Biol (1973) 1.07

Host function-dependent induction of defective interfering particles of vesicular stomatitis virus. J Virol (1978) 1.06

Low-cost hepatitis B vaccine improves uptake among self-paying health-care students. J Med Virol (1992) 1.05

Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals. J Virol (1993) 1.05

A B cell superantigen-induced persistent "Hole" in the B-1 repertoire. J Exp Med (2000) 1.05

Interchange of catalytic activity within the 2-enoyl-coenzyme A hydratase/isomerase superfamily based on a common active site template. Biochemistry (1999) 1.04

enok encodes a Drosophila putative histone acetyltransferase required for mushroom body neuroblast proliferation. Curr Biol (2001) 1.03

Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus 3 hemagglutinin-neuraminidase gene: comparison with other paramyxoviruses. Intervirology (1987) 1.03

Typing of Hantaviruses from five continents by polymerase chain reaction. Virus Res (1992) 1.02

Comparative ultrastructural study of four reticuloendothelias viruses. J Virol (1975) 1.01

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun (2008) 1.01

Mapping of functional domains for HIV-2 gag assembly into virus-like particles. Virology (1994) 1.01

Identification of the v-rel protein in REV-T transformed chicken bone marrow cells and expression in Cos1 cells. Biochem Biophys Res Commun (1986) 1.00

Hereditary breast cancer: a review. Semin Cancer Biol (2000) 0.99

Characterization of endogenous RNA-directed DNA polymerase activity of reticuloendotheliosis viruses. J Virol (1975) 0.99

Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Proc Natl Acad Sci U S A (1992) 0.98

Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients. Eye (Lond) (2004) 0.97

The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Virology (2000) 0.97

Future trends in 3D medical imaging. IEEE Eng Med Biol Mag (1990) 0.97

Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus. J Immunol (1990) 0.96

APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons. J Neurosci (1996) 0.96

3'-Terminal sequence of human parainfluenza virus 3 genomic RNA. Nucleic Acids Res (1986) 0.96

Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus type 3 fusion glycoprotein gene. J Gen Virol (1987) 0.96

Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats. Inflamm Res (2006) 0.96

Toward functional magnetic stimulation (FMS) theory and experiment. IEEE Trans Biomed Eng (1994) 0.95